GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
GERON CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.20+0.03 (+2.56%)
Close on Oct 19, 2026
- Market cap
- $804.84K
- P/E (TTM)
- –
- Dividend yield
- –
Geron statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Geron | Industry median |
|---|---|---|
| Market Cap | $770.97M | $197.05M |
| Enterprise Value | $828.46M | $106.56M |
| PB Ratio | 3.53 | 2.14 |
| P/TBV Ratio | 3.53 | 2.46 |
Income (trailing twelve months)
| Measure | Geron | Industry median |
|---|---|---|
| Operating Income | -$51.77M | -$21.44M |
| Net Income | -$67.61M | -$22.46M |
| EBITDA | -$51.28M | -$16.91M |
| EPS (Diluted) | -$0.10 | -$0.83 |
Returns
| Measure | Geron | Industry median |
|---|---|---|
| Return on Equity (ROE) | -28.3% | -53.1% |
| Return on Assets (ROA) | -12.6% | -41.0% |
| Return on Invested Capital (ROIC) | -14.2% | -32.0% |
| Return on Capital Employed (ROCE) | -11.5% | -37.8% |
Balance sheet
| Measure | Geron | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $62.64M | $62.42M |
| Total Debt | $120.13M | $120.13M |
| Net Cash (Debt) | -$57.49M | $15.68M |
| Net Cash Per Share | -$0.09 | $0.65 |
| Equity (Book Value) | $218.61M | $48.79M |
| Book Value Per Share | $0.34 | $1.36 |
| Tangible Book Value | $218.61M | $23.06M |
| Working Capital | $416.01M | $75.77M |
Financial position
| Measure | Geron | Industry median |
|---|---|---|
| Current Ratio | 6.92 | 3.30 |
| Quick Ratio | 1.62 | 2.39 |
| Debt / Equity | 0.55 | 0.51 |
| Interest Coverage | -1.71 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Geron | Industry median |
|---|---|---|
| Operating Cash Flow | -$114.38M | -$12.35M |
Efficiency
| Measure | Geron | Industry median |
|---|---|---|
| Profits Per Employee | -$1.61M | -$732.08K |
| Employee Count | 42 | 73 |
Dividends and yields
| Measure | Geron | Industry median |
|---|---|---|
| Earnings Yield | -8.77% | -21.2% |
Shares
| Measure | Geron | Industry median |
|---|---|---|
| Shares Outstanding | 642,473,000 | 59,128,900 |
| Shares Change (YoY) | 0.61% | 11.1% |
| Float | 641,205,000 | 48,744,500 |
| Shares Held by Insiders | 0.20% | 11.8% |
| Shares Held by Institutions | 76.1% | 59.4% |
Scores
| Measure | Geron | Industry median |
|---|---|---|
| Altman Z-Score | -2.89 | 0.10 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Geron's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.